BioSyent Inc. (CVE:RX – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$10.89 and traded as high as C$11.15. BioSyent ...
ICMR invites EoI for development of point-of-care serum ferritin device to diagnose iron deficiency: Shardul Nautiyal, Mumbai Tuesday, January 28, 2025, 08:00 Hrs [IST] The Indian ...